Globus Medical (GMED) PT Raised to $94 at BTIG
BTIG analyst Ryan Zimmerman raised the price target on Globus Medical (NYSE: GMED) to $94.00 (from $91.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
